Felicia Vonella | Director of Investor Relations |
Ron Cohen | President and CEO |
David Lawrence | Chief, Business and Principal Accounting Officer |
Phil Nadeau | Cowen and Company |
Thomas Shrader | Stifel Nicolaus |
Cory Kasimov | J.P. Morgan |
Paul Matteis | Leerink |
Michael Yee | Jefferies |
Laura Chico | Raymond James |
Ken Trbovich | Janney Montgomery Scott |
Salveen Richter | Goldman Sachs |
William Tanner | Cantor Fitzgerald |
Welcome to the Acorda Therapeutics Third Quarter 2017 Update. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company's request. I will now introduce your host for today's call, Felicia Vonella, Executive Director of Investor Relations at Acorda.